Product Reports Resources Pricing Login Book a demo

TMRW Life Sciences

Biotech & Life Sciences · New York City, United States · Founded 2018

Provides an integrated platform for automated, software-guided cryospecimen management MoreLess

TMRW is a pioneering startup that is revolutionizing the field of assisted reproductive technology. The company has developed the world's first and only automated platform for the safe management and storage of frozen eggs and embryos. This innovative technology is designed to serve fertility clinics and their patients, a market that is growing rapidly due to advances in reproductive technology.

TMRW's business model is centered around providing a much-needed solution to fertility clinics. These clinics are facing increasing demand for egg and embryo storage, and TMRW's platform helps them upgrade, optimize, and safely scale their operations. The platform also offers patients the highest levels of safety, security, and transparency for their precious cells.

The company's platform is FDA-cleared and uses next-generation technology to provide a new standard of care. It includes features such as digital identification and tracking, which provide unprecedented visibility and transparency. The platform's automated technology reduces manual steps and helps eliminate 93% of the potential points of failure. It also includes a 24/7 cloud-based monitoring system for peace of mind.

TMRW generates revenue by selling its platform to fertility clinics. The company's technology has been recognized as a significant advancement in IVF and is trusted by top fertility clinics.

Keywords: TMRW, fertility clinics, assisted reproductive technology, automated platform, egg and embryo storage, safety, security, transparency, FDA-cleared, cloud-based monitoring.

Company overview

TMRW Life Sciences company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2018
Headquarters
New York City, United States
Employees
66
Open positions
None listed
Dealroom signal
63.9
sub industryBioTechnologybusiness modelManufacturingsectorFertilityindustryHealthindustrySecuritysectorBiotechnologysectorFemtechsectorArts & CulturesectorBiotech and PharmasectorReproductive HealthsectorHard TechsectorDT and LSsectorscience-basedclient focusb2b

Valuation & funding

TMRW Life Sciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Apr 2026 $0 ReproTech
SERIES DOther financing Jul 2024 $28M $263M 5AM Ventures · Casdin Capital · Transformation Capital
LATE VCOther financing Dec 2022 $0 GV · 5AM Ventures · Transformation Capital · G9 Ventures
DEBTDebt Jul 2021 $53M Signature Bank
SERIES COther financing Jul 2021 $53M $210M 5AM Ventures · Casdin Capital · Anne Wojcicki · Susan Wojcicki
SERIES BOther financing Dec 2019 5AM Ventures
SERIES AOther financing May 2019 Undisclosed
Showing 7 recorded eventsUnlock the complete deal history →

Growth signals

TMRW Life Sciences website traffic

Latest recorded traffic for TMRW Life Sciences is 5K monthly website visits, up 42.9% over the last three months. TMRW Life Sciences's team declined 9.6% over the past year.

Latest monthly visits5K 3-month web change+42.9% 1-year team growth-9.6%
Monthly website visits71 observations · Dec 2018–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

TMRW Life Sciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

TMRW Life Sciences's talent

Book a demo to see the people
Team profiled 22 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

15 investors on TMRW Life Sciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
5AM Ventures
Series B+ 13 investors entered at this stage
Signature Bank
Transformation Capital
Casdin Capital
Anne Wojcicki
Susan Wojcicki
Peter Thiel
Presight Capital
Life Science Innovations
What If Ventures
GV
G9 Ventures
Amy Schumer
Ivf
Other known 1 additional known investor
ReproTech

Global footprint

Where TMRW Life Sciences has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States92.6%
🇬🇧 United Kingdom3.7%
🇺🇾 Uruguay1.9%
🇦🇷 Argentina1.9%
4 countries shown

In the news

Latest news about TMRW Life Sciences

Recent press, funding announcements, and product moves mentioning TMRW Life Sciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about TMRW Life Sciences

An AI-synthesized read of the highest-engagement posts about TMRW Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TMRW Life Sciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.